Dai-ichi Life Holdings, Inc.
DCNSF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.25 | -0.04 | 0.04 | 0.10 |
| FCF Yield | 11.05% | 119.46% | -47.32% | -83.66% |
| EV / EBITDA | 5.01 | -0.59 | -0.12 | -0.99 |
| Quality | ||||
| ROIC | 0.62% | 0.27% | 0.35% | 0.75% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 1.05 | 3.11 | -0.47 | -0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.76% | 10.10% | 3.60% | 7.36% |
| Free Cash Flow Growth | -46.02% | 407.40% | 51.86% | -290.77% |
| Safety | ||||
| Net Debt / EBITDA | -0.93 | -1.93 | -1.69 | -2.22 |
| Interest Coverage | 11.40 | 10.76 | 7.80 | 17.76 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 81.89 | 64.50 | 70.47 | 89.41 |